Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Radiology|August 1, 1987
Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two dosesB Risius, R A Graor, M A Geisinger, et al.Diseases of the Colon and Rectum|November 1, 1992
Retained mucosa after double-stapled ileal reservoir and ileoanal anastomosisS L Schmitt, S D Wexner, F V Lucas, et al.Circulation|June 1, 1986
Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulationA J Tiefenbrunn, R A Graor, A K Robison, et al.Archives of Pathology & Laboratory Medicine|January 1, 1988
Factor VIII assays. Assessment of variablesJ T Brandt, D A Triplett, K Musgrave, et al.American Journal of Clinical Pathology|May 1, 1984
Immunophenotypic characterization of acute leukemia by immunocytologyA J Fishleder, R R Tubbs, R A Savage, et al.Radiology|July 1, 1986
Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass graftsB Risius, R A Graor, M A Geisinger, et al.American Journal of Clinical Pathology|October 1, 1987
A novel whole blood capillary technic for measuring the prothrombin timeF V Lucas, A Duncan, R Jay, et al.Circulation|September 1, 1986
Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusionsR A Graor, B Risius, F V Lucas, et al.Journal of Neurosurgery|December 1, 1984
Thromboxane synthetase inhibition in acute focal cerebral ischemia in catsN A Moufarrij, J R Little, V Skrinska, et al.American Heart Journal|June 1, 1990
Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormalityR C Becker, J M Corrao, E G Bovill, et al.Pageof 5